New diabetes clinical trial: Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Participants With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

Published on: January 02, 2023 at 11:00AM
Conditions:   Obesity;   Overweight;   Type 2 Diabetes Mellitus
Interventions:   Biological: AMG 133;   Drug: Placebo
Sponsor:   Amgen
Not yet recruiting
https://ift.tt/myfPDCg